These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 6476888)
1. Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (less than or equal to 1.5 mm) melanoma. Kuehnl-Petzoldt C; Keil H; Schoepf E Arch Dermatol Res; 1984; 276(3):151-5. PubMed ID: 6476888 [TBL] [Abstract][Full Text] [Related]
2. [Clinical course of cutaneous melanoma of the head and neck, and the factors affecting patient survival]. Tarkov SA; Mikhnin AE; Shelekhova KV; Frolova OS; Nefedov AO Vopr Onkol; 2013; 59(1):114-7. PubMed ID: 23814837 [TBL] [Abstract][Full Text] [Related]
3. [Effect of mitotic density on the probability of survival of patients with thin (less than or equal to 1.5 mm) melanomas]. Kühnl-Petzoldt C; Keil H; Schöpf E Z Hautkr; 1986 Jan; 61(1-2):15-8, 23-4. PubMed ID: 3953128 [TBL] [Abstract][Full Text] [Related]
4. Malignant melanoma: influence of site of lesion and age of patient in the female superiority in survival. Shaw HM; McGovern VJ; Milton GW; Farago GA; McCarthy WH Cancer; 1980 Dec; 46(12):2731-5. PubMed ID: 7448711 [TBL] [Abstract][Full Text] [Related]
5. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment. Urist MM; Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA Ann Surg; 1984 Dec; 200(6):769-75. PubMed ID: 6508408 [TBL] [Abstract][Full Text] [Related]
6. 8-year-survival in malignant melanoma related to sex and tumor location. Weidner F Dermatologica; 1981; 162(1):51-60. PubMed ID: 7227607 [TBL] [Abstract][Full Text] [Related]
7. Survival advantage of women in localized melanoma mainly relies on clinical-pathological differences by sex. A retrospective study of 1,607 patients in Valencia, Spain. Kindem S; Garcías-Ladaria J; Requena C; Guillén C; Oliver V; Nagore E Eur J Dermatol; 2015; 25(3):247-54. PubMed ID: 25961331 [TBL] [Abstract][Full Text] [Related]
8. Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome? Fadaki N; Li R; Parrett B; Sanders G; Thummala S; Martineau L; Cardona-Huerta S; Miranda S; Cheng ST; Miller JR; Singer M; Cleaver JE; Kashani-Sabet M; Leong SP Ann Surg Oncol; 2013 Sep; 20(9):3089-97. PubMed ID: 23649930 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis. Nagore E; Oliver V; Botella-Estrada R; Moreno-Picot S; Insa A; Fortea JM Melanoma Res; 2005 Jun; 15(3):169-77. PubMed ID: 15917698 [TBL] [Abstract][Full Text] [Related]
11. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651 [TBL] [Abstract][Full Text] [Related]
12. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Balch CM; Soong S; Ross MI; Urist MM; Karakousis CP; Temple WJ; Mihm MC; Barnhill RL; Jewell WR; Wanebo HJ; Harrison R Ann Surg Oncol; 2000 Mar; 7(2):87-97. PubMed ID: 10761786 [TBL] [Abstract][Full Text] [Related]
13. Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors. Lo SN; Scolyer RA; Thompson JF Ann Surg Oncol; 2018 Apr; 25(4):894-902. PubMed ID: 29330716 [TBL] [Abstract][Full Text] [Related]
14. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma. Gimotty PA; Van Belle P; Elder DE; Murry T; Montone KT; Xu X; Hotz S; Raines S; Ming ME; Wahl P; Guerry D J Clin Oncol; 2005 Nov; 23(31):8048-56. PubMed ID: 16258103 [TBL] [Abstract][Full Text] [Related]
15. Characteristics and associations of high-mitotic-rate melanoma. Shen S; Wolfe R; McLean CA; Haskett M; Kelly JW JAMA Dermatol; 2014 Oct; 150(10):1048-55. PubMed ID: 25142970 [TBL] [Abstract][Full Text] [Related]
16. Prognostic groups of patients with stage I melanoma. Kuehnl-Petzoldt C; Wiebelt H; Berger H Arch Dermatol; 1983 Oct; 119(10):816-9. PubMed ID: 6614950 [TBL] [Abstract][Full Text] [Related]
17. [Survival analysis in patients with cutaneous malignant melanoma]. Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233 [TBL] [Abstract][Full Text] [Related]
19. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival. Cymerman RM; Shao Y; Wang K; Zhang Y; Murzaku EC; Penn LA; Osman I; Polsky D J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27235387 [TBL] [Abstract][Full Text] [Related]
20. Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck. Austin JR; Byers RM; Brown WD; Wolf P Head Neck; 1996; 18(2):107-17. PubMed ID: 8647675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]